It's unclear what Prasad's FDA exit means, but some drug makers are happy to see him go.

This reentry is notable because it poses a higher risk to the public than the US government typically allows. The risk of harm coming to anyone on Earth is still low, approximately 1 in 4,200, but it ...

Ars Technica has been separating the signal from the noise for over 25 years. With our unique combination of technical savvy and wide-ranging interest in the technological arts and sciences, Ars is ...

AWS has suffered at least two incidents linked to the use of AI coding assistants.

In September, the Trump administration took what it called “bold actions” on autism that included touting the generic drug leucovorin as a promising treatment. In a news release, Marty Makary, ...

"It's a big fat middle finger for those that thought they had something." ...

Gemini can now pull context from your files, emails, and more to create and edit documents.

Apple’s M5 Pro and M5 Max make deceptively large changes to how Apple’s high-end laptop and desktop chips are built. We’ve already covered those changes in some depth, but in essence: The M5 Pro and ...

Ars Technica has been separating the signal from the noise for over 25 years. With our unique combination of technical savvy and wide-ranging interest in the technological arts and sciences, Ars is ...

Ars Technica has been separating the signal from the noise for over 25 years. With our unique combination of technical savvy and wide-ranging interest in the technological arts and sciences, Ars is ...

Meta has acquired Moltbook, the Reddit-esque simulated social network made up of AI agents that went viral a few weeks ago. The company will hire Moltbook creator Matt Schlicht and his business ...

Ars Technica has been separating the signal from the noise for over 25 years. With our unique combination of technical savvy and wide-ranging interest in the technological arts and sciences, Ars is ...